Stratec SE (STSEY)

Market Cap	379.53M
Revenue (ttm)	266.72M
Net Income (ttm)	16.59M
Shares Out	n/a
EPS (ttm)	1.36
PE Ratio	22.88
Forward PE	13.22
Dividend	0.08 (1.47%)
Ex-Dividend Date	May 20, 2024

Volume	350
Average Volume	240
Open	5.24
Previous Close	6.70
Day's Range	5.24 - 5.24
52-Week Range	5.24 - 8.61
Beta	0.45
RSI	n/a
Earnings Date	May 30, 2025

About Stratec SE

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 a...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2018
• Employees: 1,387
• Stock Exchange: OTCMKTS
• Ticker Symbol: STSEY

Financial Performance

In 2024, Stratec SE's revenue was 257.62 million, a decrease of -4.73% compared to the previous year's 270.41 million. Earnings were 16.02 million, an increase of 4.24%.

Financial numbers in EUR